Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Faubel-Booklet Labels

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
News
Press release
shutterstock_192094955_web

Widening the focus on innovations in cancer treatment

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
Feature
pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten

Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
News

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
News
Press release
479370088_2e7091fc6e_z

Global orphan and rare dermatology market set to exceed $6 billion by 2024

August 31, 2018 Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases

The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
News
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018 Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
News
donald_trump_29496131773

Trump administration resists WHO efforts to tackle antimicrobial resistance

August 31, 2018 Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance

The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
News
astrazeneca-sign

AZ’s lupus drug fails to curb lupus activity at Phase 3

August 31, 2018 Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma

AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
News

Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer

August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Appointment
credit_natural_cycles

Contraceptive app Natural Cycles investigated over “misleading” efficacy claims

August 30, 2018 Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma

The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
News
shutterstock_4030507

Opioid prescriptions hit 15 year low, as FDA’s Gottlieb reaffirms commitment against crisis

August 30, 2018 Medical Communications FDA, opioid crisis, prescriptions, scott gottleib

The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to …
News
social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …
News

Dompé gives the FDA its first approved neurotrophic keratitis treatment

August 24, 2018 Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025